Aller au contenu principal
Profil bibliographique

Rodrigo Sampaio Chiarantano

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

18Publications signalées
30Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Lung Cancer Diagnosis and TreatmentCancer-related molecular mechanisms researchRNA modifications and cancerLung Cancer Treatments and MutationsCancer Genomics and Diagnostics

Les publications récentes

Accès ouvert 2026 article OpenAlex

Clinical and molecular characterization of a large Brazilian lung cancer cohort: a real-world observational study

Rodrigo de Oliveira Cavagna, Flávia Escremim de Paula, Gustavo Nóriz Berardinelli, Murilo Bonatelli et autres

Background Driver alterations influence lung cancer management and vary among ethnicities. Patients from Latin America remain underrepresented in genomic studies. We characterized the molecular and ancestry profiles of Brazilian patients with lung cancer using real-world data and evaluated associations with clinicopathological features. …

br, es, pt (code pays fourni par la source)

0 citations The Lancet Regional Health - Americas
Accès ouvert 2026 article OpenAlex

The LELEX initiative to enhance cancer imaging communication: development of a consensus-based structured reporting template and lexicon for general oncologic imaging

Natally de Souza Maciel Rocha Horvat, Fabio Ynoe Moraes, Lucia Antunes Chagas, Vanessa Freitas Bratti et autres

Objective: The Laudo Estruturado e Léxico em Oncologia (LELEX, Lexicon and Structured Reporting in Oncology) initiative was established to develop a standardized lexicon and structured reporting system applicable across cancer types. Methods: The São Paulo Radiology Society and Brazilian Society of Medical …

us, ca, br, fr, qa (code pays fourni par la source)

0 citations Radiologia Brasileira
Accès ouvert 2025 article OpenAlex

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Rodrigo de Oliveira Cavagna, Luciane Sussuchi da Silva et autres

The detection of actionable mutations in liquid biopsies is a crucial tool for precision oncology in patients with non-small-cell lung cancer (NSCLC). We evaluated actionable alterations using a multigene panel in circulating tumor DNA (ctDNA) from Brazilian NSCLC patients. We analyzed 32 …

br, pt (code pays fourni par la source)

1 citation Molecular Oncology
Accès ouvert 2025 article OpenAlex

Teleconsultation for Delivering Low-Dose Computed Tomography Reports in a Mobile Lung Cancer Screening Program in a Low- and Middle-Income Country: A Cross-Sectional Study

Fabiana de Lima Vazquez, Anna Luiza Silva Almeida Vicente, Welinton Yoshio Hirai, Carolina Lourenço Conceição et autres

IntroductionLung cancer is the leading cause of cancer-related death. Screening for lung cancer using low dose computed tomography (LDCT) significantly reduces lung cancer mortality. However, their implementations must be cost-effective while also prioritizing inclusivity and equity. In this context, telemedicine has emerged …

br, pt (code pays fourni par la source)

0 citations Cancer Control
2025 conference-abstract OpenAlex

Abstract 4569: MiRNA signatures in liquid biopsy for early detection of non-small cell lung cancer

Alessandro Pascon Filho, Giovanna Maria Stanfoca Casagrande, Rodrigo Sampaio Chiarantano, Fabiana de Lima Vazquez et autres

Background: Liquid biopsy-based biomarkers present a promising approach for non-invasive risk assessment and early detection of lung cancer. Aim: To identify a miRNA signature in sputum and plasma samples as a non-invasive biomarker for early detection of non-small cell lung cancer (NSCLC). …

br (code pays fourni par la source)

0 citations Cancer Research
2024 conference-abstract OpenAlex

Abstract 3661: Non-coding RNAs as biomarkers for early detection of lung cancer

Giovanna Maria Stanfoca Casagrande, Alessandro Pascon Filho, Aléxia Polo Siqueira, Rodrigo Sampaio Chiarantano et autres

Abstract Introduction: Screening programs proven to reduce lung cancer deaths in high-income countries. Biomarkers detection in body fluids may guide more precise selection of high-risk subjects but this approach has not been currently employed for lung cancer screening. Aims: To identify ncRNA-based …

br, es (code pays fourni par la source)

0 citations Cancer Research
2023 conference-abstract OpenAlex

Fluid-specific miRNA-based signatures for lung cancer screening

Giovanna Maria Stanfoca Casagrande, Rodrigo Sampaio Chiarantano, Alexia Polo, Ana Carolina Laus et autres

Introduction: Lung cancer is the deadliest cancer worldwide. Lung cancer screening has been applied in high-risk subjects and has proven to reduce lung cancer deaths in high-income countries. Biomarkers detection in body fluids may guide more precise selection of high-risk subjects but …

br, pt (code pays fourni par la source)

2 citations Lung Cancer
2023 conference-abstract OpenAlex

Use of telehealth to improve lung cancer screening program delivery of results

Ludmila Pereira Barbosa Dos Santos, Fabiana de Lima Vazquez, Letícia Ferro Leal, José Elias Miziara et autres

Introduction: Lung cancer screening has proven to reduce lung cancer deaths in high income countries. Mobile units (MU) have successfully employed lung cancer screening to increase recruitment of high-risk subjects. Although MU are able to achieve hard-to-reach populations, explaining exam results might …

br (code pays fourni par la source)

0 citations Lung Cancer

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.